Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Acorda Therapeutics, Inc. (ACOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6000-0.0900 (-3.35%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.6900
Open2.6600
Bid2.5700 x 1000
Ask2.6300 x 800
Day's Range2.5400 - 2.7600
52 Week Range2.5400 - 8.6600
Volume394,611
Avg. Volume144,412
Market Cap29.126M
Beta (5Y Monthly)0.49
PE Ratio (TTM)N/A
EPS (TTM)-17.0410
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACOR

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acorda Therapeutics, Inc.
    ACOR: Lowering target price to $0.64ACORDA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $0.635200; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
Advertisement
Advertisement